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Abstract
Background: Previous studies have indicated an increased risk of myocardial infarction (MI) in HIV infected individuals 
especially after start of highly active antiretroviral therapy (HAART). It is however controversial whether the increased 
risk of atherosclerotic disease is exclusively associated with the HIV disease and HAART or whether life-style related or 
genetic factors also increase the risk in this population. To establish whether the increased risk of myocardial infarction 
in HIV patients partly reflects an increased risk of MI in their families, we estimated the relative risk of MI in parents of 
HIV-infected individuals.
Methods: From the Danish HIV Cohort Study and the Danish Civil Registration System we identified the parents of all 
HIV-infected patients born in Denmark after 1952 in whom a Danish born mother was identifiable. For each HIV patient, 
4 matched population controls and their parents were identified. Cumulative incidence functions were constructed to 
illustrate time to first MI of the parents as registered in the Danish National Hospital Registry. Incidence rate ratios (IRR) 
were estimated by Cox's regression analyses. Due to the confidential type of the analysed data the study was approved 
by the Danish Data Protection Agency.
Results: 2,269 mothers and 2,022 fathers of HIV patients as well as 9,076 mothers and 8,460 fathers of control subjects 
were identified. We observed an increased risk of MI in mothers of HIV patients (adjusted IRR, 1.31; 95% CI: 1.08-1.60). 
The strongest association was seen in case the offspring was infected heterosexually (adjusted IRR, 1.59; 95% CI: 1.07-
2.35) or by IV drug abuse (IVD) (adjusted IRR, 1.63; 95% CI: 1.02-2.60). In fathers of HIV patients the risk of MI was only 
increased if the offspring was infected by IVD (adjusted IRR, 1.42; 95% CI: 1.01-2.00).
Conclusion: Mothers of HIV-infected patients have an increased risk of MI. We presume that this stems from family 
related life style risk factors, some of which may also influence the risk of MI in HIV-infected patients.
Background
The introduction of highly active antiretroviral therapy
(HAART) has reduced mortality and morbidity dramati-
cally in HIV-infected patients [1]. HAART has, however,
been shown to cause a number of metabolic changes and
potentially atherosclerotic complications [2,3]. Some
studies have indicated an increased risk of myocardial
infarction (MI) even in HIV patients not on HAART
[4,5]. In a study from the Danish HIV Cohort we found a
r e l a t i v e  r i s k  o f  M I  o f  1 . 3 9  i n  p a t i e n ts  n o t  o n  HAA R T
when compared to the background population [4]. The
risk was further increased following HAART initiation
(adjusted relative risk 2.12), and the risk did not increase
further during the first 8 years of HAART. This was in
contrast to the DAD-study, which concluded that the risk
of MI increased progressively with the duration of
HAART exposure [6]. Initially the main focus was on use
of protease inhibitors, but in 2008 the DAD study found
t h a t  c u r r e n t  e x p o s u r e  t o  a b a c a v i r  a n d  d i d a n o s i n e  w a s
associated with an increased risk of coronary events [7].
It is however still controversial whether the increased risk
of atherosclerotic disease is exclusively associated with
the HIV disease and HAART or whether it is also
increased due to life-style related or genetic factors.
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A family history of atherosclerotic disease is associated
with an increased risk of MI [8]. The association most
likely is mediated not only through genetic factors, but
also through shared socio-economic and environmental
factors affecting life-style e.g. smoking, diet, body mass
index, physical activity as well as the use of medical ser-
vices. Previous studies have adjusted the estimated risk of
MI for known cardiovascular risk factors [4-6,9-13], esti-
mated and compared the distribution of risk factors in
HIV patients with that of the background population
[6,14-16] or simply excluded patients with risk factors
from their study [17]. These studies though may be ham-
pered from residual confounding or confounding due to
non-measured factors. As a measure of these unac-
counted for confounders we aimed to estimate the risk of
MI in parents of HIV-infected individuals. We therefore
conducted a population based, nationwide cohort study
of the risk of MI in the parents of HIV-infected patients
compared to the risk in parents of population controls.
Methods
The study design is presented in figure 1.
Setting
As of 1 January 2007 Denmark had a population of 5.4
million (Statistics Denmark, http://www.statbank.dk),
with an estimated HIV prevalence of 0.07% among adults
[18]. Medical care, including antiretroviral treatment, is
tax-paid and provided free-of-charge to all HIV-infected
residents of Denmark.
Data sources
We used the unique 10-digit civil registration number
assigned to all individuals in Denmark to link the data
sources described below.
The Danish HIV Cohort Study
The Danish HIV Cohort Study, described in detail else-
where, is a nationwide, prospective, population-based
cohort study including all Danish HIV-infected patients
treated at Danish hospitals since 1 January 1995 [18]. The
data are updated on a yearly basis and include amongst
others demographics, route of infection, all CD4 counts,
viral loads and antiretroviral treatment.
The Danish Civil Registration System
The Danish Civil Registration System was established in
1968 and stores information of vital status, residency as
well as immigration and emigration on all Danish resi-
dents [19]. A 10-digit personal number (Central Person
Registry [CPR] number), assigned at birth, uniquely iden-
tifies each citizen. Since 1 January 1969 the registry also
included identification of parents still alive at this date.
The Danish National Hospital Registry
The Danish National Hospital Registry was established in
January 1977 and records all discharge diagnoses accord-
ing to ICD-8 and ICD-10 codes, all operation codes
according to IOC codes and since 1995 all hospital outpa-
tient visits for patients treated in Danish hospitals (The
International Classification of Diseases 8th revision until
the end of 1993 and here after 10th revision - ICD-9 has
never been used in Denmark) [20].
Definition of MI
The date of the myocardial infarction was defined as the
first date an individual was registered in the Danish
National Hospital Registry with one of the following ICD-
8 or ICD-10 diagnosis: 410.9, 410.99, I21.0-21.9.
HIV-infected patients and general population control 
cohort
The HIV patients were identified from the Danish HIV
Cohort Study (figure 1). The index date in these patients
was defined as 1 January 1995 or the date of the HIV
diagnosis which ever came last. We identified all HIV-
infected patients who: 1) were registered in the Danish
Civil Registration System, 2) born in Denmark after year
1952 (the registration of parents in the Danish Civil Reg-
istration System is incomplete for individuals born before
1953), 3) had a mother born in Denmark, who were iden-
tifiable in the Danish Civil Registration System and 4) liv-
ing in Denmark on the index date.
For each of the HIV-infected patients we identified 4
age- and gender matched population control subjects
from the Danish Civil Registration System who: 1) were
registered in the Danish Civil Registration System, 2)
born in Denmark after year 1952, 3) had a mother born in
Denmark, who were identifiable in the Danish Civil Reg-
istration System and 4) living in Denmark on the index
date of the matching HIV patient.
Study populations (parents)
We identified all Danish born parents of the HIV-infected
patients and population control subjects who were regis-
tered in the Danish Civil Registration System (figure 1).
Index date of the parents was defined as the start of the
Danish National Hospital Registry (January 1 1977) or
date of birth of the offspring which ever came last.
Statistics
We assessed the risk of MI in parents of HIV-infected
patients as well as parents of the control cohort subjects.
Time was calculated from index date to the first of the
following: - date of MI, emigration, death, lost to follow
up or 1 June 2008. We used cumulative incidence func-
tion to illustrate time to first MI registered in the Danish
National Hospital Registry, recognizing death as a com-
peting risk [21]. Incidence rate ratios (IRR) and 95% con-
fidence intervals for MI as estimates of relative risks were
calculated using Cox proportional-hazards regression.
Results were stratified on mothers and fathers. FurtherRasmussen et al. BMC Infectious Diseases 2010, 10:169
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the IRR was adjusted for: age at start of observation (con-
tinuous variable) as well as year of birth of the parent
divided into the following decades: - before1920, 1920-
1930, 1930-1940, 1940-1950, after 1950.
Cox regression analyses were stratified on route of HIV
transmission in the HIV patient (homosexual, heterosex-
ual or intravenous drug abuse (IVD)).
Statistical analyses were performed using SPSS version
17.0 and R version 2.8.1. The study was approved by the
Danish Data Protection Agency (Denmark has no Institu-
tional review boards).
Results
Of the 5,004 HIV patients in the Danish HIV Cohort
Study 2,576 were born in Denmark after 1952. Of these
2,576 patients, 90 had a mother born outside Denmark,
29 mothers had died or emigrated from Denmark before
the start of the study period (1 January 1977) and 188 had
mothers, who were untraceable in The Danish Civil Reg-
istration System leaving 2,269 individuals in the study
population (figure 1). For these individuals we identified
9,076 population controls. The demographics of the two
populations are shown in table 1.
We identified 2,269 mothers and 2,022 fathers of HIV-
infected patients as well as 9,076 mothers and 8,460
fathers of control subjects (figure 1 and table 2). The par-
ents of the HIV-infected patients were almost the same
age as that of the population controls (Table 2). Due to
the study design Denmark was registered as country of
birth in all parents. The median time of follow up was
Figure 1 Summary of the study design.Rasmussen et al. BMC Infectious Diseases 2010, 10:169
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almost 30 years in all groups and very few subjects were
lost to follow up.
During the study period the overall risk of MI was 2.08/
1,000 PYR (95% CI: 1.75-2.48) versus 1.70/1,000 PYR
(95% CI: 1.54-1.86) for mothers of HIV patients and con-
trol subjects and 5.20/1,000 PYR (95% CI: 4.60-5.87) ver-
sus 5.07/1,000 PYR (95% CI: 4.78-5.38) for fathers of HIV
patients and control subjects (Table 2).
Risk of MI was significantly higher in mothers of HIV-
infected patients compared to the control subjects
(adjusted relative risk, 1.31; 95% CI: 1.08-1.60) (Table 3
and Figure 2). The risk of MI was highest in mothers of
HIV patients who reported heterosexual contact
(adjusted relative risk, 1.59; 95% CI: 1.07-2.35) and IVD
(adjusted relative risk, 1.63; 95% CI: 1.02-2.60) as route of
HIV infection (Table 3).
Risk of MI in fathers of HIV-infected patients was
almost similar to that of control subjects (adjusted rela-
tive risk, 1.04, 95% CI: 0.90-1.19) (Table 3 and Figure 2).
However having an offspring reporting IVD as route of
infection, seemed to substantially increase the risk of MI
in the fathers (adjusted relative risk, 1.42; 95% CI: 1.01-
2.00).
Discussion and Conclusion
In this population based nation wide cohort study we
found an increased risk of MI in mothers of HIV-infected
patients compared with mothers of the general popula-
tion. The increased risk of MI was mainly seen in moth-
ers of HIV patients reporting to be infected
heterosexually or by IVD. In the fathers the increased risk
of MI was only seen in case the offspring reported IVD as
route of HIV infection.
The strength of our study is the nationwide population
based design as well as a long and complete follow-up and
the access to valid data on family members. We included
parents of HIV patients and parents of a well-matched
population control cohort. Further we were able to strat-
ify our results on several important factors as parental
gender, route of HIV transmission as well as calendar
periods. As immigrants may retain higher risk of a dis-
ease due to susceptibility periods during childhood for
Table 1: Characteristics of HIV-infected patients and population controls.
HIV-infected patients Control subjects
Number of study subjects 2,269 9,076
Males (number (%)) 1,895 (83.5) 7,580 (83.5)
Median age at index date (years (IQR)) 33.8 (29.2-38.7) 33.8 (29.2-38.7)
Route of infection:
Homosexual (number (%)) 1,205 (53.1)
Heterosexual (number (%)) 555 (24.5)
Injection drug abuse (number (%)) 336 (14.8)
Other/unknown (number (%)) 173 (7.6)
Table 2: Characteristics of parents of HIV-infected patients and population controls.
Mothers of Fathers of
HIV-infected patients Control subjects HIV-infected patients Control subjects
No of parents 2,269 9,076 2,022 8,460
Median age at index date (years (IQR)) 38.3 (32.3-44.9) 38.7 (32.4-45.3) 41.5 (34.6-49.1) 41.9 (34.6-49.2)
Number in whom observation time started after 
1. January 1977 (%)
197 (7.9) 699 (7.7) 200 (8.8) 773 (8.1)
First admission with MI after index date: 129 (5.7) 434 (4.8) 257 (12.7) 1,085 (12.8)
Emigration during follow-up, N (%) 19(0.8) 35 (0.4) 18 (0.9) 44 (0.5)
Lost to follow-up, N (%) 0 (0.0) 1 (0.0) 1 (0.0) 3 (0.0)
Duration of follow up
Duration of follow-up, person years 61,900 256,033 49,443 213,883
Duration of follow-up, median years (IQR) 31.4 (25.9-31.4) 31.4 (28.3-31.4) 29.9 (18.7-31.4) 31.0 (20.6-31.4)
Overall risk of MI, per 1,000 PYR (95%CI) 2.08 (1.75-2.48) 1.70 (1.54-1.86) 5.20 (4.60-5.87) 5.07(4.78-5.38)Rasmussen et al. BMC Infectious Diseases 2010, 10:169
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some diseases as well as the potential effect of accultura-
tion, immigrants were excluded from our study [22,23].
In the start of the epidemic in the 1950s coronary heart
disease was associated with high socio-economic status,
but over time became a disease of the lower social classes.
This, as well as the fact that treatment and prevention of
ischaemic heart disease has changed considerably over
time, makes control of calendar periods essential [8,24].
We are not aware of other studies with a similar design.
Our study has some limitations. To identify patients
with the MI diagnosis we relied on hospital registry based
discharge diagnoses, which may not be entirely accurate
and includes a risk of incorrectly registered diagnoses due
to pre-hospital death. Importantly though we used the
same source of data to ascertain MI for all study objects.
Furthermore identification of MI on behalf of discharge
diagnoses has previously been shown to be valid [25]. We
could not adjust for specific indicators of social class and
socio-economic status such as parental education, occu-
pation, family income, housing conditions, maternal mar-
ital status or illegitimacy. However, reported route of HIV
infection in the offspring may act as a surrogate marker
for socio-economic status.
Denmark harbours well-designed registries, which pro-
vide full access to data on all inhabitants concerning vital
status and hospital contacts. As the Danish National Hos-
pital Registry was not initiated until January 1977, some
of the study subjects (i.e. the parents) might have had MI
prior to study inclusion. These subjects are at increased
risk of MI and ideally should have been excluded. How-
ever, as the Danish National Hospital Registry does not
allow us to distinguish between first and subsequent epi-
Table 3: Risk of MI in parents of HIV- infected patients and population controls.
Mothers: Fathers:
Unadjusted IRR (95% CI) Adjusted IRR (95% CI) Unadjusted IRR (95% CI) Adjusted IRR (95% CI)
All parents 1.25 (1.03-1.52) 1.31 (1.08-1.60) 1.03 (0.90-1.18) 1.04 (0.901.19)
Parents of homosexual 
patients
1.11 (0.84-1.48) 1.10 (0.82-1.47) 0.98 (0.81-1.18) 0.94 (0.78-1.13)
Parents of heterosexual 
patients
1.46 (0.99-2.15) 1.59 (1.07-2.35) 1.02 (0.77-1.35) 1.07 (0.81-1.41)
Parents of IV-drug addicts 1.31 (0.82-2.08) 1.63 (1.02-2.60) 1.31 (0.94-1.83) 1.42 (1.01-2.00)
Figure 2 Cumulative incidence of hospitalization with MI in mothers and fathers.Rasmussen et al. BMC Infectious Diseases 2010, 10:169
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sodes of MI in case the first MI occurred before 1977, we
have no means of excluding these patients. Nevertheless,
this phenomenon could hardly have biased our results
substantially as the study subjects were young at inclu-
sion, which makes previous episodes of MI unlikely. Fur-
ther, age at study inclusion did not differ markedly
between the compared groups (mothers versus mothers,
fathers versus fathers) and therefore the proportion of
post MIs misclassified as primary MI probably did not
differ between groups. The relative risk measures there-
fore would remain rather unchanged even in case of
inclusion of some post MI subjects. Parents were not
included in the study if they had never been registered as
parents in the Danish Civil Registration System, or had
died prior to year 1977 as diagnoses of MI in the Danish
National Hospital Registry were first available from that
year. In 188 cases (7.6%) we were not able to trace the
mothers in The Danish Civil registration System. We pre-
sume that the bias this may introduce is equivalent in the
patient/control populations and does not influence our
estimates.
In general the absolute risk of MI is higher in males
than in females. However, in our study the increase in rel-
ative risk of MI was substantially higher in the mothers
compared to the fathers. Several factors may explain this
observation. First low socio-economic class, associated
with particular lifestyle patterns, has been described as a
stronger risk factor of MI for women than for men [26].
Second the offspring may be more prone to share life
style characteristics with their mothers than their fathers
possible due to a preponderance of single family homes
with mothers raising the children. And third the absolute
risk of MI was almost three times higher in the fathers
compared to the mothers. Therefore a minor increase in
absolute risk of MI in the mothers will result in a greater
increase in relative risk in this population compared to
the fathers.
Although ischaemic heart disease manifests itself in
adulthood, the disease and underlying atherosclerosis,
develops throughout life [23]. An increased risk of MI has
previously been shown to be associated with lower social
class in adulthood [22,23,27]. However, adverse circum-
stances during pregnancy and childhood, including poor
socio-economic conditions, seem to be important deter-
minants of risk of adult cardiovascular disease. These risk
factors are not merely due to the continuity of disadvan-
tage throughout life [8,23,24,28]. In a study by Kaplan et
al it was suggested that HIV-infected individuals from
economically disadvantaged populations bear a dispro-
portionate burden of risk factors that might explain the
association of MI and HIV [27]. In addition to this it has
previously been established that the prevalence of smok-
ers are consistently higher in HIV patients than in age-
matched controls [14,27,29-31]. We cannot exclude that
smoking may be a major contribution to the increased
r i s k  o f  M I  i n  p a r e n ts  o f  H IV  p a t i e n t s  a c t i n g  i n d e pe n -
dently of other risk factors.
Our results showed a strong association between IVD
as route of HIV infection in the offspring and risk of MI
in both mothers and fathers of HIV patients. A strong
association between initiation of IVD in the offspring and
adverse socio-environmental factors in childhood has
been described and this association probably explains the
association observed in our study [32,33].
Our study cannot unambiguously discriminate to what
extend genetic and environmental factors exert their
impact on risk of MI in the parents of HIV patients. But
the findings imply that shared socio-economic disadvan-
tages to some extent explain the excess risk of MI
observed in the mothers. The genetic element in MI is
not to be questioned but to our knowledge no genetic fac-
t o r s  h a v e  b e e n  d e s c r i b e d ,  w h i c h  i s  a s s o c i a t e d  w i t h
increased risk of both HIV acquisition and MI. However,
health-risk behaviours are frequently interrelated [34]
and tendency to "risk taking behaviour" has been
explained as a result of a complex combination of social
(e.g. socio-economic and environmental factors), genetic
and developmental factors [35-39]. In that case initiating
IVD, sharing needles and having sex without barrier pro-
tection as well as heavy smoking, alcohol consumption,
inappropriate diet and physical inactivity, could all be a
result of the same genetic predisposition.
The increased risk of MI in HIV infected individuals
has mainly been ascribed to the HIV infection per se and
exposure to HAART [4-7,11,12,15-17,40]. Additionally it
has been questioned whether a HIV-positive status sim-
ply serves as a marker for differences in the prevalence of
conventional risk factors such as smoking [29]. We found
an increased risk of MI in mothers of HIV patients of
almost the same order (IRR: 1.31) as that seen in their
HIV infected offspring when not on HAART (IRR: 1.39)
[4]. Our data therefore indicate that a main proportion of
the increased risk of MI in these mothers and their HIV-
infected offspring may stem from the same family related
life style factors.
The implications of our findings extend beyond estab-
lishing the risk of MI in the parents of the HIV infected
patients. Recent studies suggest premature aging, acceler-
ated cognitive decline, increased risk of non-AIDS associ-
ated cancers and osteoporosis in HIV infected patients
despite successful HAART [41]. These studies may
potentially be hampered by substantial influence from
family related risk factors as well. Thus our data indicate
that the association between risk for common diseases
and HIV exposure may make it difficult to definitively
establish HIV or antiretroviral drugs as causal risk factors
for comorbidity in HIV infected patients.Rasmussen et al. BMC Infectious Diseases 2010, 10:169
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In conclusion, mothers of HIV-infected patients have
increased risk of MI. We presume, that the increased risk
is related to family related life style risk factors, some of
which may also influence the risk of MI in the HIV-
infected patients. Thus, a major fraction of the increased
risk of MI observed in HIV-infected patients may stem
from non-HIV-related factors.
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